Logo

Berry & Associates Inks Oligo Tech Licensing Deal with Fluorous Technologies

Feb 14, 2005

NEW YORK, Feb. 14 (GenomeWeb News) - Berry & Associates has signed a technology licensing deal with Fluorous Technologies for use of its fluorous synthesis and separation technology, the companies said today.

 

Under the deal, Berry will be able to use the Fluorous Technologies separation technology in a line of fluorous-adapted oligonucleotide synthesis products.

 

Specific terms of the arrangement were not disclosed.

Breaking News
The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.